Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dong Wook Oh
Efficacy and Safety of Pembrolizumab in Patients With Refractory Advanced Biliary Tract Cancer: Tumor Proportion Score as a Potential Biomarker for Response
Cancer Research and Treatment
Cancer Research
Oncology
Related publications
The Efficacy and Safety of Different Pharmacological Interventions for Patients With Advanced Biliary Tract Cancer: A Network Meta-Analysis
Oncotarget
Oncology
Biweekly Cisplatin and Gemcitabine in Patients With Advanced Biliary Tract Cancer
International Journal of Cancer
Cancer Research
Oncology
16S rDNA Microbiome Composition Pattern Analysis as a Diagnostic Biomarker for Biliary Tract Cancer
World Journal of Surgical Oncology
Surgery
Oncology
Exposure–response Analysis and Simulation of Lenvatinib Safety and Efficacy in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Apatinib Monotherapy as a Second-Line Treatment for Patients With Advanced Biliary Tract Cancer: A Retrospective Single-Center Observational Study
Phase I Clinical Trial of Multiple-Peptide Vaccination for Patients With Advanced Biliary Tract Cancer
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Investigating Safety and Preliminary Efficacy of Afm13 Plus Pembrolizumab in Patients With Relapsed/Refractory Hodgkin Lymphoma After Brentuximab Vedotin Failure
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficacy of Fluoropyrimidine-Based Chemotherapy in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin: Retrospective Analysis of 321 Patients
British Journal of Cancer
Cancer Research
Oncology
EGFR and HER2 Expression in Advanced Biliary Tract Cancer
Zeitschrift fur Gastroenterologie
Medicine
Gastroenterology
